TABLE 4.
Results of Respiratory Viral Panel Tests
| All (n = 108) N, % | SARS-CoV-2 Positive (n = 27) N, % | SARS-CoV-2 Negative (n = 81) N, % | P Value | |
|---|---|---|---|---|
| Human rhinovirus | 56 (51.9%) | 9 (33.3%) | 47 (58.0%) | 0.03 |
| RSV A/B | 30 (27.8%) | 6 (22.2%) | 24 (29.6%) | 0.46 |
| Adenovirus | 10 (9.3%) | 5 (18.5%) | 5 (6.2%) | 0.06 |
| Human enterovirus | 2 (1.9%) | 1 (3.7%) | 1 (1.2%) | 0.41 |
| Human Bocavirus | 3 (2.8%) | 1 (3.7%) | 2 (2.5%) | 0.74 |
| HCoV-229E | - | - | - | - |
| HCoV-NL-63 | - | - | - | - |
| Influenza A/B | 1 (0.9%) | 1 (3.7%) | - | - |
| Parainfluenza | 1 (0.9%) | - | 1 (1.2%) | - |
| Human metapneumovirus | 1 (0.9%) | - | 1 (1.2%) | - |
| Other respiratory virus detected | 71 (65.7%) | 15 (55.6%) | 56 (69.1%) | 0.20 |
| Single respiratory virus | 44 (40.7%) | 7 (25.9%) | 37 (45.7%) | 0.80 |
| Multiple respiratory viruses | 27 (25.0%) | 8 (29.6%) | 19 (23.5%) | 0.52 |